JACC. Cardiovascular interventions Alkhouli Mohamad, etal Comparative Outcomes of Intracardiac vs Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion: Insights From EMERGE LAA Postapproval Study 2025
Journal of the American College of Cardiology Ramanathan P. Kasi, etal TCT-220 Real-world Utilization of PASCAL Precision System in non-A2P2 Degenerative Mitral Regurgitation 86:17, p. B97 2025
Journal of the American College of Cardiology Alkhouli Mohamad, etal TCT-606 Comparative Outcomes of Intracardiac versus Transesophageal Echocardiography Guidance for Left Atrial Appendage Occlusion with Amulet Device: Insights from EMERGE LAA Post-Approval Study 86:17, p. B263 2025
JACC. Cardiovascular interventions Waggoner Thomas, etal Early U.S. Commercial Experience With a Novel Transcatheter Edge-to-Edge Repair System 18:16, p. 2036 - 2046 2025
Cardiovascular revascularization medicine Shah Atman P., etal Outcomes for single antiplatelet, dual antiplatelet, or oral anticoagulation after Amulet: Insights from EMERGE LAA post-approval study 2025
JACC. Clinical electrophysiology Ellis Christopher R, etal Concomitant Catheter Ablation and Left Atrial Appendage Occlusion With the Amulet Occluder From EMERGE LAA Post-Approval Study 2025
Journal of the American College of Cardiology Lakkireddy Dhanunjaya, etal TCT-531 One-Year Real-World Outcomes With the Amulet Occluder From the EMERGE LAA Post-Approval Study 84:18, p. B182 - B182 2024
JAMA neurology Maarse Moniek, etal Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation 2024
JACC. Cardiovascular interventions Aarnink Errol W, etal Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication 2024
JACC. Cardiovascular interventions Alkhouli Mohamad, etal First Experience With Amulet in the United States 17:3, p. 422 - 434 2024
JACC. Cardiovascular interventions Alkhouli Mohamad, etal Amulet Occluder Implantation in Patients With Failed Prior Left Atrial Appendage Occlusion: EMERGE LAA Insights 17:3, p. 457 - 459 2024
JACC. Cardiovascular interventions Alkhouli Mohamad, etal First Experience With Amulet in the United States: Early Insights From EMERGE LAA Postapproval Study 2024
JACC. Cardiovascular interventions Mesnier Jules, etal Persistent and Recurrent Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes 16:22, p. 2722 - 2732 2023
Cardiovascular revascularization medicine Aggarwal Gaurav, etal Orbital Atherectomy During Percutaneous Coronary Intervention for Severely Calcified Coronary Lesions in Patients With and Without Diabetes Mellitus: A Meta-Analysis 53, p. S12 - 2023
Cardiovascular revascularization medicine Aggarwal Gaurav, etal Transcatheter Aortic Valve Replacement With Self-Expanding Acurate Neo2 Valve Versus Acurate Neo Valve: A Meta-Analysis 53, p. S105 2023
Cardiovascular revascularization medicine Aggarwal Gaurav, etal Transcatheter Aortic Valve Replacement in Patients With and Without Concomitant Aortic Aneurysm: A Meta-Analysis 53, p. S114 2023
Cardiovascular revascularization medicine Benito-González Tomás, etal Left Atrial Appendage Occlusion With Watchman® Device in Patients With Non-Valvular Atrial Fibrillation and End-Stage Chronic Kidney Disease on Hemodialysis (EPIC06 - WATCH-HD) 53, p. S120 - S121 2023
JACC. Cardiovascular interventions Aggarwal Gaurav, etal CRT-100.59 Orbital Atherectomy During Percutaneous Coronary Intervention for Severely Calcified Coronary Lesions in Patients With and Without Diabetes Mellitus: A Meta-Analysis 16:4, p. S3 - S3 2023
JACC. Cardiovascular interventions Aggarwal Gaurav, etal CRT-700.64 Transcatheter Aortic Valve Replacement in Patients With and Without Concomitant Aortic Aneurysm: A Meta-Analysis 16:4, p. S96 - S97 2023
JACC. Cardiovascular interventions Aggarwal Gaurav, etal CRT-700.19 Transcatheter Aortic Valve Replacement With Self-Expanding Acurate Neo2 Valve Versus Acurate Neo Valve: A Meta-Analysis 16:4, p. S88 - S89 2023
JACC. Cardiovascular interventions Benito-González Tomás, etal CRT-700.55 Left Atrial Appendage Occlusion With Watchman® Device in Patients With Non-Valvular Atrial Fibrillation and End-Stage Chronic Kidney Disease on Hemodialysis (EPIC06 - WATCH-HD) 16:4, p. S102 - S102 2023
Catheterization and cardiovascular interventions Ismayl Mahmoud, etal Impact of sex on in-hospital mortality and 90-day readmissions in patients undergoing transcatheter mitral valve replacement (TMVR): Analysis from the nationwide readmission database 101:2, p. 407 - 416 2023
Coronary artery disease Thandra Abhishek, etal Sex difference in clinical and procedural outcomes in patients undergoing coronary atherectomy: a systematic review and meta-analysis 33:8, p. 634 - 642 2022
Hagström Emil, etal Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab 2022
Journal of the American College of Cardiology Ismayl Mahmoud, etal Impact of Sex on In-hospital Mortality and Readmission Rates in Patients Undergoing Transcatheter Mitral Valve Replacement (TMVR): A National Readmission Database Study 79:9, p. 879 - 879 2022
Journal of the American College of Cardiology Schwartz Gregory G., etal Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol 78:5, p. 421 - 433 2021
Journal of the American College of Cardiology Simard Trevor, etal Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion 78:4, p. 297 - 313 2021
JACC: Case Reports Kousa Omar, etal Left Atrial Appendage Closure in a Patient With a Patent Foramen Ovale Septal Occluder Device 3:3, p. 508 - 511 2021
HeartRhythm Case Reports Tandon Tarun S., etal Left atrial appendage closure in a patient with situs inversus totalis and interrupted inferior vena cava – A transhepatic approach 6:11, p. 871 - 874 2020
JACC: Cardiovascular Interventions Van Mieghem Nicolas M., etal Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial 13:3, p. 323 - 331 2020
Roe Matthew T, etal Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes 2019
Szarek Michael, etal Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial 2019
Jukema J Wouter, etal Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial 2019
White Harvey D, etal Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial 2019
The Lancet Diabetes and Endocrinology Ray Kausik K., etal Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes 7:8, p. 618 - 628 2019
Steg Philippe Gabriel, etal Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial 2019
Szarek Michael, etal Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial 2019
New England Journal of Medicine Schwartz G. G., etal Alirocumab and cardiovascular outcomes after acute coronary syndrome 379:22, p. 2097 - 2107 2018
JACC: Cardiovascular Interventions Guddeti Raviteja R., etal Massive Inferior Vena Cava Thrombosis Associated With Retroperitoneal Venolymphatic Malformation 11:22, p. e187 - e188 2018
Journal of the American College of Cardiology Haddad Toufik Mahfood, etal TCT-272 Outcomes of Drug-Eluting versus Bare-Metal Stents in Saphenous Vein Graft Lesions: A Meta-Analysis of Randomized Controlled Trials 72:13, p. B112 - B112 2018
JACC. Cardiovascular interventions Kanmanthareddy Arun, etal CRT-800.25 Second Generation Versus First Generation Transcatheter Aortic Valve Replacement: A Meta-analysis 10:3, p. S71 - S71 2017
Journal of the American College of Cardiology saurav alok, etal TCT-816 Trend of Utilization & Procedural Outcomes of Endomyocardial Biopsy in United States: A Nationwide Inpatient Sample Based Study 68:18, p. B330 - B331 2016
Cardiology Madias John E., etal Stability of the ECG features of complete right bundle branch block over time 103:2, p. 84 - 88 2005
Annals of Noninvasive Electrocardiology Madias John E., etal Diagnosis of ventricular aneurysm and other severe segmental left ventricular dysfunction consequent to a myocardial infarction in the presence of right bundle branch block 10:1, p. 53 - 59 2005
American Journal of Cardiology Madias John E., etal Effect of weight loss in congestive heart failure from idiopathic dilated cardiomyopathy on electrocardiographic QRS voltage 89:1, p. 86 - 88 2002
Journal of Electrocardiology Madias John E., etal Diagnosis of myocardial infarction-induced ventricular aneurysm in the presence of complete left bundle branch block 34:2, p. 147 - 154 2001
Madias J. E., etal ST-segment elevation in leads V1-V3 in patients with LBBB [1] 2001
Journal of the American College of Cardiology Madias John E., etal Anasarca-mediated attenuation of the amplitude of electrocardiogram complexes 38:3, p. 756 - 764 2001
Clinical Cardiology Madias John E., etal A critique of the new ST-segment criteria for the diagnosis of acute myocardial infarction in patients with left bundle-branch block 24:10, p. 652 - 655 2001
Journal of Electrocardiology Madias J. E., etal Unusual ECG responses to exercise stress testing 34:3, p. 265 - 269 2001
Journal of electrocardiology Madias John E., etal Marked reduction of ECG voltage in patients with anasarca: A new ECG syndrome 33, p. 176 - 176 2000